Clover Health’s (CLOV) wholly owned subsidiary Counterpart Health, an AI-powered physician-enablement platform, released a whitepaper which finds that patients whose primary care physicians used Counterpart Assistant’s flu-related clinical insight were 1.89 times more likely to receive a flu vaccination, and patients with COPD and CHF experienced significantly fewer flu-related hospitalizations and emergency visits. By fusing dozens of health-data streams with up-to-date clinical guidelines, CA delivers real-time recommendations that help Primary Care Physicians mitigate these risks. A relationship with a CA PCP was also associated with a lower rate of flu-related acute care utilization for patients with certain high-risk chronic diseases. For patients with chronic obstructive pulmonary disease. Similarly, for patients with congestive heart failure.
Claim 30% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
- Clover Health Highlights Transparency With Supplemental Earnings Q&A
- Clover Health becomes first player live on CMS Aligned Network
- Clover Health price target lowered to $2.75 from $3 at UBS
- Clover Health reports Q4 EPS (10c), consensus (5c)
- Clover Health sees FY26 revenue $2.81B-$2.92B, consensus $2.74B
